Anaplastic thyroid carcinoma (ATC) is the rarest, but deadliest histologic type among thyroid
malignancies, with a dismal median survival of 3-9 mo. Even though ATC accounts for less …

Anaplastic thyroid carcinoma (ATC) is a rare malignancy, accounting for 1–2% of all thyroid
cancers. Although rare, ATC accounts for the majority of deaths from thyroid carcinoma. ATC …

Anaplastic thyroid cancer (ATC) is a rare tumour but also one of the most lethal
malignancies. Therapeutic modalities have usually been limited, but clinical trials with new …

Anaplastic thyroid cancer (ATC) is an uncommon malignancy of the thyroid. Only 1‐2% of
thyroid cancers are anaplastic, but the disease contributes to 14–50% of the mortality with a …

Simple Summary Anaplastic thyroid carcinoma (ATC) has a dismal prognostic.
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …

Anaplastic thyroid cancer represents 1%–2% of thyroid cancers. For its aggressiveness, it is
considered a systemic disease at the time of diagnosis. Surgery remains the cornerstone of …

Anaplastic thyroid carcinoma (ATC) is an orphan disease and in most patients fatal. So far
no established treatment is available that prolongs survival. Several large retrospective …

Background Anaplastic thyroid carcinoma (ATC), accounting for 5% to 15% of primary
malignant thyroid neoplasms, is one of the most aggressive solid tumors in humans …

Opinion statement Anaplastic thyroid cancer (ATC) is a rare but very aggressive form of
undifferentiated thyroid cancer. Due to its rapid rate of progression and invasive nature, ATC …

Globally, thyroid cancer accounts for 2% of all cancer diagnoses, and can be classified as
well-differentiated or undifferentiated. Currently, differentiated thyroid carcinomas have good …